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Hypoglycemia continues to be a serioush a z a rd for all patients with type 1 dia-betes and is the major obstacle in the
achievement of tight glycemic control (1).
The main defense against a severe episode
of hypoglycemia, resulting in coma or con-
vulsion, is the adequate recognition of
falling glucose levels (2). This re c o g n i t i o n
relies on an intact counterre g u l a t o ry
defense mechanism, usually generating an
autonomic symptom complex that alert s
the individual to the falling glucose.
C h i l d ren appear to be at greater risk of
s e v e re hypoglycemia (3,4). The precise re a-
son for this is unclear, although it may in
p a rt re p resent the inability of young chil-
d ren to express autonomic symptoms to
the same degree (5). There have been few
studies of glucose counterregulation in
childhood, and most of these have been in
the adolescent population. The results have
shown both exaggerated hormone re l e a s e
(6,7) and blunted responses (8,9), diff e r-
ences which may be explained by diff e re n t
methods of inducing hypoglycemia (insulin
infusion or hyperinsulinemic clamp).
N o c t u rnal hypoglycemia is a special
p roblem. It is common in children and
adults with type 1 diabetes (10–13), yet,
despite many episodes being profound and
p rolonged, the majority are asymptomatic,
even in individuals with good awareness of
hypoglycemia during waking hours (14).
The possibility of modified counterre g u l a-
t o ry responses during sleep, resulting in
defective nighttime awareness, has been
little studied, and the results so far are con-
flicting. Nocturnal hypoglycemia in adults
p rovoked greater catecholamine re l e a s e
than daytime hypoglycemia (14), where a s
adolescents studied during slow wave sleep
w e re found to have significantly blunted
catecholamine responses (15).
N o c t u rnal hypoglycemia is more com-
mon in young pre p u b e rtal children (12,16)
than in adolescents, and younger childre n
may also be more vulnerable to any long-
t e rm adverse effects of hypoglycemia (17).
The possibility that impaired counterre g u-
l a t o ry responses contribute to this serious
p roblem has been little studied. We re p o rt
a study perf o rmed in a group of pre p u b e r-
tal children with type 1 diabetes to examine
the counterre g u l a t o ry hormone re s p o n s e s
to spontaneous overnight hypoglycemia.
RESEARCH DESIGN AND 
M E T H O D S — Studies were appro v e d
by the Central Oxford Research Ethics
Committee, and consent was obtained
f rom the parents, once assent had been
obtained from the childre n .
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C o u n t e rregulation During Spontaneous
N o c t u rnal Hypoglycemia in Pre p u b e rt a l
C h i l d ren With Type 1 Diabetes
O R I G I N A L  A R T I C L E
O B J E C T I V E — To examine counterre g u l a t o ry responses during spontaneous nocturn a l
hypoglycemia in pre p u b e rtal children with type 1 diabetes.
RESEARCH DESIGN AND METHODS — A total of 29 pre p u b e rtal patients with type 1
diabetes underwent two overnight pro files. Data were analyzed from 16 children (median
[range] 8.7 [5.9–12.9] years of age) with a night of hypoglycemia and a nonhypoglycemic
night. Children hypoglycemic (,3.5 mmol/l) on night 1 were given 25% extra carbohydrate
as uncooked corn s t a rch with their usual evening snack on night 2 to avoid hypoglycemia. Glu-
cose, growth hormone, and cortisol were measured every 15 min, catecholamines every 30 min,
and glucagon, pancreatic polypeptide, insulin, and ketones every 60 min. A group of 15 healthy
c o n t rol subjects, aged 9.5 (5.6–12.1) years, underwent one overnight pro fil e .
R E S U LT S — Median duration of hypoglycemia was 225 (30–630) min, and glucose nadir
was 2.0 (1.2–3.3) mmol/l. Insulin levels were not diff e rent on the two nights (P = 0.9, analy-
sis of variance), but children with diabetes had higher insulin levels than normal control sub-
jects between 2300 and 0300, maximal at 0200 (mean ± SEM 57.4 ± 5.7 vs. 31.6 ± 5.0 pmol/l,
P = 0.002). Peak epinephrine was higher on the night of hypoglycemia (0.98 [0.52–2.09]
nmol/l) versus nonhypoglycemia (0.32 [0.21–0.62] nmol/l), P = 0.001, but nore p i n e p h r i n e
(1.29 [1.07–2.64] vs. 1.26 [1.04–1.88] nmol/l, P = 0.5), glucagon (93 [64.2–125.6] vs. 100.5
[54.6–158] ng/l, P = 0.6), pancreatic polypeptide (410.2 [191–643.2] vs. 270.8 [158.2–777.8]
ng/l, P = 0.5), and cortisol (513 [300–679] vs. 475 [235–739] nmol/l, P = 0.6) were not dif-
f e rent. Glucose threshold for epinephrine release was very low, 1.9 ± 0.2 mmol/l. There was a
s h o rt-lived rise in growth hormone from 75–105 min after onset of hypoglycemia, maximal at
90 min (7.8 ± 1.2 vs. 3.5 ± 0.9 ng/ml, P = 0.02).
C O N C L U S I O N S — The prolonged nature of nocturnal hypoglycemic episodes may be
explained in part by defective counterregulation. The risk of nocturnal hypoglycemia needs to
be reduced before intensification of insulin therapy can be contemplated in this age-group. 
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C h i l d ren were re c ruited from the pedi-
atric diabetic clinic of the John Radcliff e
Hospital, Oxford, U.K., on the basis of their
willingness to participate. Pre p u b e rtal chil-
d ren over the age of 5 years, with a diabetes
duration of . 12 months and with no other
s i g n i Þ cant medical condition, were eligible
to participate. Of a total of 52 eligible chil-
d ren, 29 were studied. All children were on
conventional insulin regimens, re c e i v i n g
twice-daily mixtures of soluble and iso-
phane insulin.
A group of 15 healthy children, sib-
lings or friends of children attending the
diabetic clinic, were also studied to pro v i d e
n o rmal overnight metabolic data (Table 1).
Studies on the children with type 1 dia-
betes took place in their home following a
n o rmal dayÕs routine as re g a rds diet, activity,
and dose of insulin. Two overnight meta-
bolic pro Þ les were perf o rmed 1—2 weeks
a p a rt. At 1930, an intravenous cannula was
sited on the dorsum of the hand, and
patency was maintained with heparinized
n o rmal saline. Samples for HbA1 cw e re taken
at 2000 and for C-peptide at 0700. Ve n o u s
samples were taken in the home for glucose
e v e ry 15 min between 2000—0800, but ana-
lyzed the following day. Hypoglycemia was
d e Þ ned as a blood glucose , 3.5 mmol/l on
two successive 15-min measure m e n t s .
Of the 29 children, 16 had a night of
hypoglycemia and a night of nonhypo-
glycemia for comparison. Characteristics
of these children are summarized in Table 1.
Ten were hypoglycemic on study night 1
and were given 25% extra carbohydrate in
the form of uncooked corn s t a rch with their
usual evening snack on night 2.
Blood was taken for growth horm o n e
(GH) and cortisol every 15 min, and for
f ree insulin and ketones every 60 min.
Eight of these children had samples ana-
lyzed for glucagon and pancreatic polypep-
tide (PP); selection was purely on the basis
of sample availability.
The Þnal eight children to take part 
in the study also had blood taken 
for catecholamines, and comparison be-
tween hypoglycemic (n = 7) and nonhypo-
glycemic nights (n = 9) were not in the
same childre n .
In the 15 children without diabetes,
samples were taken for GH and glucose
e v e ry 15 min and insulin and ketones every
60 min. Seven of these children also had
blood taken for catecholamines every 30
min, for glucagon every 60 min, and for
c o rtisol every 120 min.
Biochemical analysis
Samples for measurement of blood glucose
w e re collected into ßuoride tubes and
s t o red at room temperature over- n i g h t .
Whole blood glucose was measured using a
glucose oxidase method (YSI analyzer;
Clandon ScientiÞc, Farn b o rough, Hamp-
 h i re, U.K.). HbA1 c was measured by high-
p e rf o rmance liquid chro m a t o g r a p h y
(HPLC) (Diamat, Bio-Rad, Hemel Hemp-
stead, U.K.), normal range 4.3—6.1%. The
intra-assay coefficients of variation were 1.9
and 2.2% at HbA1 c levels of 6.9 and 11.5%,
re s p e c t i v e l y. The interassay coefficients of
variation were 2.7 and 2.3% at HbA1 c l e v e l s
of 7.0 and 11.6%, re s p e c t i v e l y.
Samples for GH analysis were initially
kept at room temperature until completion
of each study, before being spun and sep-
arated for storage at 2 2 0° C. Plasma GH
was then measured by immunoradiomet-
ric assay (NETRIA, St. Bart h o l o m e w Õs Hos-
pital, London, U.K.) using an intern a t i o n a l
re f e rence standard 80/505. All samples
f rom each individual were analyzed in the
same batch. The intra-assay coefficients of
variation at GH concentrations of 1.1, 5.6,
and 27.1 ng/ml were 8.0, 2.0, and 3.4%,
re s p e c t i v e l y, while interassay coeff i c i e n t s
of variation at GH concentrations of 1.4,
5.9, and 30.2 ng/ml were 9.4, 7.7, and
10.5%, re s p e c t i v e l y.
Plasma glucagon was measured by
radioimmunoassay using guinea pig anti-
human glucagon antibodies speciÞc for
p a n c reatic glucagon, 1 2 5I-labeled glucagon
as tracer, and glucagon standards, with
reagents supplied by Linco Research, St.
Charles, MO. Inter- and intra-assay coeff i-
cients of variation were 5—10%.
PP was assayed by double antibody
radioimmunoassay using rabbit anti-
human PP antibodies, 1 2 5I-labeled human
P P, and human PP standard with rea g e n t s
supplied by Linco Researc h .
For catecholamine analysis, samples
w e re added to EGTA/glutathione pre s e rv a-
tive, spun for 10 min, and then separated
immediately before being stored at 2 80° C .
Epinephrine and norepinephrine were
extracted from 50-µl samples of plasma
with an organic solvent method and sepa-
rated and quantiÞed by HPLC with 
 l e c t rochemical detection (18). Intra-assay
c o e ficients of variation were 4% for nore p-
inephrine and 6% for epinephrine; interas-
say values were 6 and 8%, re s p e c t i v e l y.
F ree insulin was measured by Þrs t
mixing 1.0 ml of whole blood into a 25%
solution of polyethylene glycol 6000
( M e rck, Dorset, U.K.) to remove insulin
antibodies (19). This was then centrifuged
and the supernatant separated and store d
at 2 2 0° C until assayed with a double
antibody radioimmunoassay (Diagnostic
Systems Laboratories, We b s t e r, TX). The
intra-assay coefficients of variation were
8.2, 4.8, and 6.3% at 29, 106, and 328
pmol/l, re s p e c t i v e l y. The interassay coeff i-
cients of variation were 11.2, 9.2, and
4.7% at 30, 97, and 318 pmol/l, re s p e c-
t i v e l y. Polyethylene glycol was not added
to samples from nondiabetic childre n .
C o rtisol was measured using a coated
tube radioimmunoassay (DPC, Llanberis,
U.K.). The intra-assay coefficient of varia-
tion at levels of 86, 552, and 938 nmol/l
was 4.8, 3.0, and 4.4%, re s p e c t i v e l y. The
interassay coefficient of variation at levels of
91, 579, and 993 nmol/l was 5.2, 4.0, and
6.4%, re s p e c t i v e l y.
Ketones (acetoacetate and b- hy d ro x y-
butyrate) were assayed using a standard
technique (20,21) after the addition of ice-
cold 10% perchloric acid and separation 
f samples.
Data analysis
O v e rnight comparisons were made using
analysis of variance (ANOVA) for re p e a t e d
m e a s u res using log-transformed data. Peak
data were deÞned as the maximal level
Table 1—Demographic details of diabetic and nondiabetic part i c i p a n t s
Type 1 diabetic subjects Control subjects
n 1 6 1 5
Age (years) 8.7 (5.9 to 12.9) 9.5 (5.6 to 12.1)
H b A1 c ( % ) 8.7 (6.9 to 10.3) 5.3 (5.1 to 5.7)
Duration (years) 3.1 (1.1 to 10.2) Ñ
Insulin dose (U ?k g2 1 ?d a y2 1) 0.8 (0.5 to 1.1) Ñ
BMI SD 0.34 (2 1.14 to 1.89) 2 0 . 4 8 (2 1.48 to 2.00)
Positive C-peptide status 4 Ñ
Data are n or medians (range).
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achieved overnight and area under the curv e
(AUC) data were calculated using the trape-
zoidal method. Comparisons between the
night of hypoglycemia and the nonhypo-
glycemic night were made using nonpara-
metric, paired analyses except in the case of
catecholamines, where unpaired analyses
w e re used. Data were also compared with
data obtained from the nondiabetic childre n .
Serial array averaging was used to exam-
ine the effect of the onset of hypoglycemia
on the release of cortisol and GH for the sub-
sequent 2 h, in 16 paired pro files. The point
of hypoglycemia was identified as the time at
which the glucose level first fell below 3.5
mmol/l, and a comparison was made of suc-
cessive 15-min values during hypoglycemia,
and the corresponding time points from the
night without hypoglycemia, using t tests. A
glucose threshold for epinephrine re l e a s e
was also calculated, this being defined as the
glucose level at which epinephrine rose by
.2 SD above basal levels.
Data are shown as medians (range) or
means ± SEM, unless otherwise stated. A 
P value ,0.05 was taken to be signific a n t .
The computer program SPSS 7.5 for Wi n-
dows 95 was used for statistical analyses.
R E S U LT S
Glucose
Mean blood glucose levels were 5.2 ± 0.5
mmol/l during the night of hypoglycemia
and 10.3 ± 0.8 mmol/l during the nonhy-
poglycemic night in 16 children where
p a i red comparisons were possible (Fig.
1A). The median glucose nadir was 2.0
(range 1.2–3.3) mmol/l on the night of
hypoglycemia. The median duration of
these paired episodes of hypoglycemia was
225 (30–630) min. The median time of
glucose nadir was 0345 (2145–0645), and
the median time of onset of hypoglycemia
was 0115 (2100–0515).
Despite a slight fall in glucose levels
during the early part of the night, none of
the nondiabetic children had a blood glu-
cose ,3.5 mmol/l overnight (mean ± SEM,
4.3 ± 0.1 mmol/l).
Free insulin
F ree insulin levels were not signific a n t l y
d i ff e rent between the night of hypogly-
cemia and the night without using either
A N O VA (P = 0.9) or AUC (P = 0.4). Using
u n p a i red comparisons of insulin data at
matched time points, insulin levels were
s i g n i ficantly higher in children with dia-
betes on both nights when compared with
n o rmal control subjects between 2300–
0300 (Fig. 1B) .
Median levels of insulin at the time of
onset of hypoglycemia were not diff e re n t
f rom those obtained at the same time point
on the night without hypoglycemia (95.4
[range 17.9–211.7] vs. 68.2 [17.9–137.0]
pmol/l, P = 0.06). During six episodes of
hypoglycemia, low glucose levels persisted
for 245 ± 41 min despite insulin levels at
the lower limit of detection of the assay
(17.9 pmol/l).
Ketones
Only b- h y d roxybutyrate will be pre s e n t e d
because acetoacetate results were similar.
Ketone levels were suppressed at the
beginning of the night but increased as
insulin levels waned (Fig. 1C). There were
no overnight diff e rences in b- h y d ro x y b u-
tyrate between the night of hypoglycemia
and the night without, as defined by
A N O VA, P = 0.08. However, peak values
w e re significantly higher on the night of
hypoglycemia, P = 0.01 (Table 2), and the
AUC data were also significantly gre a t e r, 
P = 0.01 (Table 3).
Comparing data from the night of
hypoglycemia with data obtained from the
nondiabetic control subjects, there were no
s i g n i ficant diff e rences in either peak levels
or AUC.
GH
Mean overnight levels of GH were similar
on the night of hypoglycemia and the night
Figure 1—A: Glucose profiles on the night of
hypoglycemia (s) and the night without (d) .
The gray shaded area re p resents the range of glu -
cose values from the overnight pro files of childre n
without diabetes. B and C: Insulin and b- h y d ro x -
ybutyrate (BOH) pro files on the night of hypogly -
cemia (s) and the night without (d). The gray
shaded area represents the 95% CIs of the values
from the children without diabetes. *Significant
d i ff e rence (P , 0.05) at these time points
between the values in children with and those
without diabetes.
Table 2—Peak re s p o n s e s
n Hypoglycemia No hypoglycemia Control subjects
Epinephrine (nmol/l) 8 0.98 (0.52–2.09)* 0.32 (0.21–0.62) 0.52 (0.13–1.91)
N o repinephrine (nmol/l) 8 1.29 (1.07–2.64) 1.26 (1.04–1.88) 1.59 (0.71–2.58)
Glucagon (ng/l) 8 93 (64.2–125.6) 100.5 (54.6–158) 76.5 (60.3–8 1 . 3 )
PP (ng/l) 8 443.6 (191–6 4 3 . 2 ) 257.6 (158.2–777.8) —
C o rtisol (nmol/l) 1 6 513 (300–6 7 9 ) 475 (235–739) 477 (384–552)
b- h y d roxybutyrate (mmol/l) 1 6 0.29 (0.04–0 . 5 3 ) † 0.12 (0.02–0 . 4 4 ) 0.13 (0.03–0 . 5 1 )
Acetoacetate (mmol/l) 1 6 0.14 (0.02–0 . 2 8 ) ‡ 0.09 (0.03–0 . 2 1 ) 0.10 (0.03–0 . 2 7 )
Data are n or medians (range). n = number of children with type 1 diabetes in whom sample analysis was possible. *P = 0.001, †P = 0.01, ‡P = 0.02 for hypoglycemia
vs. no hypoglycemia.
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without hypoglycemia (4.8 ± 0.5 vs. 4.3 ±
0.5 ng/ml, P = 0.3) (Fig. 2E). Furt h e rm o re ,
mean levels from the night without hypo-
glycemia and mean levels from the nondi-
abetic control subjects were not sig-
n i ficantly diff e rent (4.3 ± 0.5 vs. 3.5 ± 0.3
ng/ml, P = 0.2).
When analyzed by serial array averaging,
a small rise in GH levels was detected
75–105 min following the onset of hypogly-
cemia (diff e rence maximal at 90 min, 7.8 ±
1.2 vs. 3.5 ± 0.9 ng/ml, P = 0.02), and 
levels remained higher until 105 min 
(Fig. 3A). After this time, values were similar
to that on the night without hypoglycemia.
Cortisol
T h e re were no diff e rences in cortisol levels
between the night of hypoglycemia and
the night without hypoglycemia (Fig. 2D)
when analyzed by ANOVA, AUC, or peak
levels (Tables 2 and 3). When comparing
data from the night without hypoglycemia
with that obtained from the nondiabetic
c o n t rol subjects, there were no signific a n t
d i ff e rences in either peak levels or AUC 
(P = 0.5 and 0.3, respectively). No change
in cortisol levels after hypoglycemia was
detected by serial array averaging (Fig. 3B) .
Glucagon
T h e re were no significant increases in
glucagon during hypoglycemia (Fig. 2A)
detected either by ANOVA (P = 0.7), peak
levels achieved (P = 0.9) (Table 2), or 
AUC values (P = 0.4) (Table 3). Generally,
absolute levels were not diff e rent when
c o m p a red with nondiabetic childre n .
PP
Fasting PP levels were analyzed (fasting
values taken from the midnight sample).
T h e re were no significant diff e re n c e s
between the night of hypoglycemia and
the nonhypoglycemic night, by ANOVA 
(P = 1.0), by peak levels (P = 0.5), or by
AUC (P = 1.0) (Tables 2 and 3).
Table 3—AUC data
n Hypoglycemia No hypoglycemia Control subjects
Epinephrine (nmol ? l21 ? 12 h) 8 277 (121–357)* 132 (89–245) 150 (84–244)
N o repinephrine (nmol ? l21 ? 12 h) 8 747 (662–874)* 628 (533–746) 772 (354–993)
Glucagon (ng ? l21 ? 12 h) 8 44,385 (36,579–6 6 , 4 7 4 ) 50,118 (28,632–8 1 , 0 6 3 ) 42,980 (38,676–47,790)
PP (ng ? l21 ? 8 h) 8 87,828 (57,516–108,042) 64,074 (50,004–172,176) —
C o rtisol (nmol ? l21 ? 12 h) 1 6 144,330 (83,040–274,920) 148,140 (86,940–211,440) 126,540 (101,700–163,980)
b- h y d roxybutyrate (mmol ? l21 ? 12 h) 1 6 50.1 (12.0–132.6)* 26.2 (7.1–8 0 . 5 ) 42.5 (3.8–155.6)
Acetoacetate (mmol ? l21 ? 12 h) 1 6 52.1 (9.3–98.9)* 39.6 (15.8–6 1 . 2 ) 47.4 (11.8–114.4)
Data are n or medians (range). n = number of children with type 1 diabetes in whom sample analysis was possible. *P , 0.01 for hypoglycemia vs. no hypoglycemia.
F i g u re 2—C o u n t e rre g u l a t o ry hormone pro files for glucagon (A), epinephrine (B), norepinephrine (C) ,
c o rtisol (D), and GH (E) on the night of hypoglycemia (s) and the night without (d). The gray shaded
areas represent the 95% CIs of the values from the children without diabetes.
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Catecholamines
Peak epinephrine levels (Fig. 2B) were
s i g n i ficantly higher on the night of hypo-
glycemia (0.98 [0.52–2.09] nmol/l) than
on the nonhypoglycemic night (0.32
[0.21–0.62] nmol/l) (P = 0.001), with a
mean increment from baseline of 0.9 ± 0.3
nmol/l (Table 2). Although peak levels after
hypoglycemia were higher than those
o b s e rved in the nondiabetic control sub-
jects, this diff e rence did not achieve statis-
tical significance (0.98 [0.52–2.09] vs. 0.52
[0.13–1.91] nmol/l, P = 0.09).
The mean glucose threshold for sig-
nificant epinephrine release was 1.9 ± 
0.2 mmol/l. The time between the glucose
falling below 3.5 mmol/l and a signific a n t
i n c rement in epinephrine (.2 SD above
baseline) was 170 ± 24 min. No corre l a-
tion was observed between changes in
epinephrine and subsequent change in
blood glucose.
Although no significant diff e rences in
n o repinephrine pro files were observed by
A N O VA and peak levels were no diff e re n t
( Table 2) (Fig. 2C), the AUC was signific a n t l y
higher on the night of hypoglycemia when
c o m p a red to the night without (Table 3).
C O N C L U S I O N S — In this study, we
found a high prevalence of severe hypogly-
cemia of long duration in young children on
conventional insulin regimens. Insulin lev-
els were higher in the middle of the night
than those seen in nondiabetic control sub-
jects, re flecting the kinetics of interm e d i a t e -
acting insulins given in the evening (22).
Hypoglycemia also persisted even when
insulin levels waned, suggesting defective
c o u n t e rregulation. Ketone levels were sup-
p ressed in the early part of the night, when
insulin levels were high, and then rose grad-
ually in the early hours of the morning as
insulin levels waned. Although peak ketone
levels were higher following a night of
hypoglycemia, they were not signific a n t l y
d i ff e rent from those observed in contro l
subjects. This lack of a significant rise also
suggests defective counterre g u l a t i o n .
We examined counterre g u l a t o ry re -
sponses during these episodes of sponta-
neous nocturnal hypoglycemia. Blood was
taken for catecholamimes only on the last
eight children to take part in the study, so
p a i red comparison of these data was not
possible. Although we found a signific a n t
rise in epinephrine in response to hypogly-
cemia, the mean peak response of 0.98
nmol/l was small when compared to pre v i-
ous studies (6,7). In one of those studies, in
which a hyperinsulinemic clamp was used
to induce hypoglycemia, peak epinephrine
levels were threefold greater than those
found in our study (6). In that study, both
p u b e rtal and pre p u b e rtal children were
studied, and epinephrine was still higher
when their data were analyzed separately. In
contrast, a more recent study of adolescents,
again using a hyperinsulinemic clamp,
found that increases in epinephrine were
s i g n i ficantly lower when compared with the
nondiabetic control subjects, although the
i n c rement of 1.9 nmol/l was still gre a t e r
than that found in our subjects (9). These
d i s c repancies could be explained by the
younger age of our study group, because
peak epinephrine responses have been
found to increase with the age of the child
(8). In the only study of pre–school-age chil-
d ren experiencing re c u rrent severe hypo-
glycemia, epinephrine responses were again
higher than those found in our study, with
an incremental value of 2 nmol/l (23). In
addition to the low peak levels, the glucose
t h reshold for epinephrine release was 
1.9 mmol/l, which is much lower than the
p reviously re p o rted threshold of 3.6 mmol/l
found in healthy children and the thre s h o l d
of 3.0 mmol/l for adults from the same study
(24). It is possible that the diff e rences seen in
our study, compared with the previous stud-
ies quoted, may have been the spontaneous
n a t u re of the episodes we studied. We also
found a marked time delay between the glu-
cose falling below 3.5 mmol/l and the rise in
epinephrine, 170 min, in contrast to the
n o rmal rapid response in stepped hyperin-
sulinemic-hypoglycemic clamp studies. The
markedly blunted and delayed epinephrine
responses to hypoglycemia in our pre p u-
b e rtal subjects suggests that counterre g u l a-
t o ry failure may be responsible for the lack
of glucose re c o v e ry overn i g h t .
Glucagon responses to hypoglycemia
have been found to be defective in adults
within 2–5 years of the development of
type 1 diabetes, irrespective of the pre s e n c e
of other counterre g u l a t o ry or autonomic
a b n o rmalities; the precise reason for this is
unclear (25,26). We also found no signifi-
cant change in glucagon even following
p rofound nocturnal hypoglycemia, and
this is in agreement with other studies in
c h i l d ren. Blunted glucagon responses have
been consistently re p o rted (6,7) even in
the youngest children with the short e s t
duration of diabetes (23). There is evi-
dence that autonomic activation con-
tributes to the glucagon response to
hypoglycemia in the absence of diabetes
(27,28). Because our children have
i m p a i red autonomic responses, as evi-
F i g u re 3—Serial array averaging for consecutive 15-min values for GH (A) and cortisol (B) after onset
of hypoglycemia (0 min). s, night of hypoglycemia; d, night without. *Significant diff e rence (P 0 . 0 5 )
at these time points between hypoglycemia and no hypoglycemia.
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denced by the reduced epinephrine (sym-
pathetic) and blunted PP (parasympa-
thetic) responses, it is possible that this is
one reason why glucagon levels do not
i n c rease, despite profound hypoglycemia
(27). The autonomic impairment is likely
to be a result of previous hypoglycemia
(29) rather than autonomic neuro p a t h y, in
view of the short duration of diabetes.
Glucagon and epinephrine are the fir s t -
line hormones in the acute re c o v e ry fro m
hypoglycemia, whereas GH and cortisol are
c o n s i d e red to be of lesser importance in the
h i e r a rchy of counterre g u l a t o ry horm o n e s
unless hypoglycemia is prolonged (2). In our
study we found no significant changes in
c o rtisol despite prolonged hypoglycemia.
P revious studies have indicated variable cor-
tisol responses, with re p o rts of similar
i n c reases in children with diabetes and con-
t rol subjects (6,7), smaller increases (9), and
no increases in either children with diabetes
or control subjects (23). Given the lack of
i n c rease in cortisol levels and the presence of
other evidence suggestive of defective coun-
t e rregulation, it was surprising to find a
small rise in GH in response to hypogly-
cemia. However, the magnitude and short
duration of the response indicate that it is
unlikely to be effective in restoring glucose
levels. In previous studies of counterre g u l a-
tion, the GH response to hypoglycemia was
p re s e rved in subjects with diabetes
(6,7,9,23). In one study of 24-h pro files in
c h i l d ren with diabetes, GH responses were
in fact greater when hypoglycemia occurre d
during the night than during the day,
although some of this diff e rence may re l a t e
to the fact that daytime episodes were symp-
tomatic and there f o re treated (30).
T h e re may be a number of reasons to
explain the diff e rences we have found in
our study group compared with that found
in previous studies. We considered the pos-
sibility that the 16 children who had one
night of hypoglycemia were not re p re s e n t a-
tive of the group as a whole; thus we com-
p a red mean hormone responses on the
night without hypoglycemia in these chil-
d ren with responses in the 9 children who
did not become hypoglycemic on either
night (the remaining children had two
nights of hypoglycemia). We found no
s i g n i ficant diff e rences in mean ketone,
insulin, cortisol, or GH levels between the
two groups or the nondiabetic control sub-
jects (data not shown). A potential weak-
ness of our study is the lack of control data
for normal counterre g u l a t o ry responses to
hypoglycemia in these young children. Eth-
ical considerations would prevent the study
of induced hypoglycemia in these young
c h i l d ren, and so we have relied on 
data comparisons from other studies
(6–9,23,24). In this respect it is import a n t ,
when comparing our results with pre v i o u s
studies of hypoglycemia in children, to con-
sider that all episodes occurred at night
while the children were asleep. Bendtson et
al. (14) examined the possibility that hor-
monal responses to hypoglycemia are
a l t e red by sleep, which could provide an
explanation for the lack of symptoms of
hypoglycemia occurring during sleep. They
found that hormonal responses to induced
hypoglycemia were either similar or gre a t e r
at night than during the day, although they
did not control for the stage of sleep at the
time of hypoglycemia. However, Jones et al.
(15) found significantly diminished epi-
nephrine responses during hypoglycemia
induced during stage 3/4 sleep when com-
p a red with hypoglycemia either during the
day or at night when the patient was awake.
I n t e re s t i n g l y, they also found pre s e rved GH
responses to hypoglycemia, even during
sleep, despite blunting of cortisol and
glucagon. In our study, the wide variability
in the time of onset of hypoglycemia and
the long duration of the episodes make it
d i fficult to interpret hormonal responses in
relation to sleep staging. Nevertheless, the
possibility that counterregulation may be
entrained to sleep stage, re flecting altere d
c e rebral metabolism at diff e rent times of
the night (31), remains an interesting ques-
tion that deserves further investigation.
The possible defective counterre g u l a-
tion we have observed in these young chil-
d ren may have its origins in prior episodes
of hypoglycemia, occurring either during
the day or at night, that had gone unde-
tected. Studies in nondiabetic adults have
found that even one episode of nocturn a l
hypoglycemia can lead to subsequent defi-
ciencies in glucoregulation (29), yet this
finding has not been confirmed in diabetic
adults (32). It is possible that in young chil-
d ren, who may have a poor understanding
of the practical issues surrounding their ill-
ness together with an inability to art i c u l a t e
their symptoms, repeated episodes of hypo-
glycemia that go undetected could lead to
i m p a i red counterregulation to subsequent
episodes of hypoglycemia. Further study is
re q u i red to study this hypothesis.
In summary, we have shown a high fre-
quency of profound asymptomatic noctur-
nal hypoglycemia of long duration in
young children on standard insulin therapy.
Although these episodes may be pre c i p i-
tated by overinsulinization during the early
p a rt of the night, their prolonged nature
may result from defective counterre g u l a-
tion. These data provide strong evidence
that intensification of insulin therapy may
be especially hazardous in this age-gro u p .
A c k n o w l e d g m e n t s— K.M. was supported by a
fellowship from the British Diabetic Associa-
tion. P.H. was supported by National Institutes
of Health Grants DK-50129 and DK- 35747
and from the JDF. The project was supported by
a grant from Novo Nordisk Pharm a c e u t i c a l s .
The authors would like to acknowledge 
D. Forster, D. Harris, Z. Madgewick, K. Stanhope,
and A. Watts for their technical assistance. 
R e f e re n c e s
1 . The Diabetes Control and Complications
Trial Research Group: The effect of inten-
sive treatment of diabetes on the develop-
ment and pro g ression of long-term
complications in insulin-dependent dia-
betes mellitus. N Engl J Med 3 2 9 : 9 7 7 – 9 8 6 ,
1 9 9 3
2 . Amiel S: Glucose counter- regulation in
health and disease: current concepts in
hypoglycaemia recognition and re s p o n s e .
Q J M 293:707–727, 1991
3 . Daneman D, Frank M, Perlman K, Tamm J,
Ehrlich R: Severe hypoglycemia in childre n
with insulin-dependent diabetes mellitus:
f requency and predisposing factors. J Pediatr
115:681–685, 1989
4 . Davis EA, Keating B, Byrne GC, Russell M,
Jones TW: Hypoglycemia: incidence and
clinical predictors in a large population-
based sample of children and adolescents
with IDDM. Diabetes Care 20:22–25, 1997
5 . McCrimmon RJ, Gold AE, Deary IJ, Kelnar
CJH, Frier BM: Symptoms of hypoglycemia
in children with IDDM. Diabetes Care
6:858–861, 1995
6 . Amiel SA, Simonson DC, Sherwin RS, Lau-
ritano AA, Tamborlane WV: Exaggerated
epinephrine responses to hypoglycemia in
n o rmal and insulin-dependent diabetic
c h i l d ren. J Pediatr 110:832–837, 1987
7 . Jones TW, Boulware SD, Kraemer DT,
Caprio S, Sherwin RS, Tamborlane WV:
Independent effects of youth and poor dia-
betes control on responses to hypoglycemia
in children. D i a b e t e s 40:358–363, 1991
8 . H o ffman RP, Singer-Granick C, Drash AL,
Becker DJ: Plasma catecholamine re s p o n s e s
to hypoglycemia in children and adoles-
cents with IDDM. Diabetes Care 1 4 : 8 1 – 8 8 ,
1 9 9 1
9 . B j o rgaas M, Vik T, Sand T, Birkeland K, Sager
G, Vea H, Jorde R: Counterre g u l a t o ry and
symptom responses to hypoglycaemia in 
diabetic children. Diabet Med 1 4 : 4 3 3 – 4 4 1 ,
1 9 9 7
1150 DIABETES CARE, VOLUME 22, NUMBER 7, JULY 1999
N o c t u rnal counterregulation in childre n
1 0 . Gale EAM, Tatersall RB: Unrecognised noc-
t u rnal hypoglycaemia in insulin-tre a t e d
diabetics. L a n c e t i:1049–1052, 1979
11. Pramming S, Thorsteinsson B, Bendtson
I, Ronn B, Binder C: Nocturnal hypogly-
caemia in patients receiving tre a t m e n t
with insulin. Br Med J 291:376–379, 1985
1 2 . B e regszaszi M, Tu b i a n a - ru fi N, Benali K,
Noel M, Bloch J, Czernichow P: Nocturn a l
hypoglycemia in children and adolescents
with insulin-dependent diabetes mellitus:
p revalence and risk factors. J Pediatr
131:27–33, 1997
1 3 . P o rter PA, Keating B, Byrne G, Jones TW:
Incidence and predictive criteria of noctur-
nal hypoglycemia in young children with
insulin-dependent diabetes mellitus. J Pediatr
130:366–372, 1997
1 4 . Bendtson I, Rosenfalck AM, Binder C: Noc-
t u rnal versus diurnal counterregulation to
hypoglycemia in type 1 (insulin-depen-
dent) diabetic patients. Acta Endocrinol
128:109–115, 1993
1 5 . Jones TW, Porter P, Sherwin RS, Davis EA,
O ’ L e a ry P, Frazer F, Byrne G, Stick S, Ta m-
borlane WV: Decreased epinephrine re -
sponses to hypoglycemia during sleep. 
N Engl J Med 338:1657–1662, 1998
1 6 . Lopez MJ, Oyarzabal M, Barrio R, Herm o s o
F, Lopez JP, Rodriguez M, Blasco L, Gastaldo
E: Nocturnal hypoglycaemia in IDDM
patients younger than 18 years. Diabet Med
14:772–777, 1997
1 7 . Golden MP, Ingersoll GM, Brack CJ, Russell
BA, Wright JC, Huberty TJ: Longitudinal
relationship of asymptomatic hypoglycemia
to cognitive function in IDDM. D i a b e t e s
C a re 12:89–93, 1989
18. Forster CD, Taylor JY, Macdonald IA: The
assay of the catecholamine content of
small volumes of human plasma. In Mon -
itoring Molecules in Neuroscience Proceed -
ings of 5th International Conference on In
Vivo Methods. Rollema H, We s t e rnik 
BHC, Drijfhout WJ, Eds. Groningen, the
Netherlands, University of Gro n i n g e n ,
1991, p. 173–175
1 9 . Collins ACG, Pickup JC: Sample pre p a r a-
tion and radioimmunoassay for circ u l a t i n g
f ree and antibody bound insulin concen-
trations in insulin treated diabetics: a re -
evaluation of methods. Diabet Med
2:456–460, 1985
2 0 . Mellanby J, Williamson DH: Acetoacetate.
In Methods of Enzymatic Analysis. Vol. 4.
B e rgmayer HV, Ed. New York, Academic,
1974, p. 1840–1843
2 1 . Williamson DH, Mellanby J: D-(-)-3-
h y d roxybutyrate. In Methods of Enzymatic
A n a l y s i s. Vol 4. Bergmayer HV, Ed. New
York, Academic, 1974, p. 1836–1839
2 2 . Roy B, Chou MC, Field JB: Ti m e - a c t i o n
characteristics of regular and NPH insulin
in insulin treated diabetes. J Clin Endocrinol
M e t a b 50:475–479, 1980
2 3 . Brambilla P, Bougneres PF, Santiago JV,
Chaussin JL, Pouplard A, Castano L: Glu-
cose counterregulation in pre - s c h o o l - a g e
c h i l d ren with re c u rrent hypoglycemia dur-
ing conventional treatment. D i a b e t e s
36:300–304, 1987
2 4 . Jones TW, Borg WP, Boulware SD,
M c C a rthy G, Sherwin RS, Tamborlane WV:
Enhanced adre n o m e d u l l a ry response and
i n c reased susceptibility to neuro g l y c o p e-
nia: mechanisms underlying the adverse
e ffects of sugar ingestion in healthy chil-
d ren. J Pediatr 126:171–177, 1995
2 5 . Bolli GB, De Feo P, Compagnucci P, Cart e-
chini MG, Angeletti G, Santeusanio F,
B runetti P, Gerich JE: Abnormal glucose
c o u n t e rregulation in insulin-dependent
diabetes mellitus: interaction of anti-insulin
antibodies and impaired glucagon secre-
tion. D i a b e t e s 32:134–141, 1983
2 6 . Gerich JE, Langlois M, Noacco C, Karam
JH, Forsham PH: Lack of a glucagon
response to hypoglycemia in diabetes: evi-
dence for an intrinsic pancreatic alpha cell
d e f e c t . S c i e n c e 182:171–173, 1973
2 7 . Taborsky GJ Jr, Ahren B, Havel PJ: Auto-
nomic mediation of glucagon secre t i o n
during hypoglycemia: implications for
i m p a i red a-cell responses in type-1 dia-
betes. Diabetes 47:995–1005, 1998
28. Havel PJ, Ahren B: Activation of auto-
nomic nerves and the adrenal medulla
contributes to increased glucagon secre-
tion during moderate insulin-induced
hypoglycemia in women. Diabetes 4 6 : 8 0 1 –
807, 1997
2 9 . Veneman T, Mitrakou A, Mokan M, Cryer P,
Gerich J: Induction of hypoglycemia un-
a w a reness by asymptomatic nocturnal hypo-
glycemia. D i a b e t e s 42:1233–1237, 1993
3 0 . Winter RJ: Pro files of metabolic control in
diabetic children: frequency of asympto-
matic nocturnal hypoglycaemia. M e t a b o -
lism 7 : 6 6 6 – 6 7 2 , 1 9 8 1
3 1 . Maquet P, Dive D, Salmon E, Sadzot B,
Franco G, Poirrier R, von Franckell R,
Franck G: Cerebral glucose utilization
during the sleep-wake cycle in man deter-
mined by positron emission tomo-
graphy and 1 8F - 2 - flu o ro - 2 - d e o x y - D - g l u-
cose method. Brain Res 5 1 3 : 1 3 6 – 1 4 3 ,
1 9 9 0
3 2 . G e o rge E, Marques JL, Harris ND, Mac-
donald IA, Hardisty CA, Heller SR: Pre s e r-
vation of physiological responses to
hypoglycemia 2 days after antecedent
hypoglycemia in patients with IDDM. D i a -
betes Care 20:1293–1298, 1997
